Thirumalai Chemicals Limited has informed the Exchange about commencement of start-up activities of TCL Specialties LLC, USA (TCLS USA), a step-down wholly owned subsidiary of Thirumalai Chemicals Limited
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thirumalai Chemicals' step-down wholly owned subsidiary, TCL Specialties LLC, USA, has started the first phase of commercial operations at its new US manufacturing facility with the first sale of Maleic Anhydride (MAN). The facility includes a MAN plant with a capacity of about 40,500 tons per year and a Food Ingredients plant of over 30,000 tons per year for Malic acid and Fumaric acid. The phased commissioning is expected to be fully completed and stabilized during the first half of calendar year 2026. From this facility, TCLS USA will serve MAN customers in the North-Eastern, Mid-West US and other regional markets that are currently underserved.
This is a positive development for shareholders as it marks the commercial launch of a sizeable new US asset, opening a new revenue stream in a large overseas market. Near-term contribution may be limited as full ramp-up continues through H1 CY2026, but successful stabilization could meaningfully expand the company's earnings base over time.